Profile
| Metric | Value |
|---|---|
| Full Name | Immatics N.V. |
| Ticker | NASDAQ: IMTX |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | Germany |
| IPO | |
| Indexes | Not included |
| Website | immatics.com |
| Employees | 646 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $10.30 | |
| Price, 1D Change | +6.96% | |
| $1B | ||
| - | ||
| - | ||
| 1.38 | ||
| $169M | ||
| Revenue, 1Y Change | +188.75% | |
| $0.15 | ||
| EPS, 1Y Change | +112.13% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | ARYA | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| $0.15 | ||
| EPS Estimate | -$1.97 | |
| EPS Est. Change | -1,379.10% | |
| $168.57M | ||
| Revenue Estimate | $47.74M | |
| Revenue Est. Change | -71.68% | |
| Current Price | $10.30 | |
| Price Target | - | - |
| Price Tgt. Change | - | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$1.32 | -$1.27 | +3.76% | |
| -$0.69 | $0.15 | +122.39% | |
| -$1.97 | N/A | -1,379.10% | |
| -$1.84 | N/A | -1,291.76% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $56.53M | $58.38M | +3.27% | |
| $121.27M | $168.57M | +39.00% | |
| $47.74M | N/A | -71.68% | |
| $48.51M | N/A | -71.22% |
🔒 Log In To Unlock Full Data
Performance
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $10.30 | |
| $7.67 | ||
| SMA 200 vs Price | -25.49% | |
| $9.97 | ||
| SMA 50 vs Price | -3.24% | |
| 1.38 | ||
| $0.66 | ||
| 55.62 | ||
| 99.35% | ||
| 71.98% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $168.57M | ||
| $0.15 | ||
| $0.00 | ||
| 0.00% | ||
| -$41.79M | ||
| -24.78% | ||
| $16.46M | ||
| 9.77% | ||
| $37.29M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.03 | ||
| 9.26 | ||
| 9.26 | ||
| 25.09 | ||
| 1 | ||
| 6.72 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| 15.18 | ||
| 2.82 | ||
| -6.09 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $595.25M | ||
| $625.91M | ||
| $720.86M | ||
| $651.90M | ||
| $125.61M | ||
| $70.40M | ||
| $18.57M | ||
| $4.74M | ||
| $21.43M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $210.46M | ||
| $210.46M | ||
| - | ||
| $50.27M | ||
| $13.23M | ||
| $959.00K | ||
| $6.63M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$171.04M | ||
| -$164.94M | ||
| $346.01M | ||
| $17.84M | ||
| -$188.88M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Chardan Capital | → | |
| Mizuho | → | |
| Guggenheim | → | |
| Guggenheim | ||
| Deutsche Bank | ||
| Cantor Fitzgerald | → | |
| B of A Securities | → | |
| Piper Sandler | ||
| Cantor Fitzgerald | ||
| Cantor Fitzgerald |
Analyst sentiment
Institutional ownership
Screeners with IMTX
FAQ
What is the ticker symbol for Immatics N.V.?
The ticker symbol for Immatics N.V. is NASDAQ:IMTX
Does Immatics N.V. pay dividends?
No, Immatics N.V. does not pay dividends
What sector is Immatics N.V. in?
Immatics N.V. is in the Healthcare sector
What industry is Immatics N.V. in?
Immatics N.V. is in the Biotechnology industry
What country is Immatics N.V. based in?
Immatics N.V. is headquartered in Germany
When did Immatics N.V. go public?
Immatics N.V. initial public offering (IPO) was on December 12, 2018
Is Immatics N.V. in the S&P 500?
No, Immatics N.V. is not included in the S&P 500 index
Is Immatics N.V. in the NASDAQ 100?
No, Immatics N.V. is not included in the NASDAQ 100 index
Is Immatics N.V. in the Dow Jones?
No, Immatics N.V. is not included in the Dow Jones index
When was Immatics N.V. last earnings report?
Immatics N.V.'s most recent earnings report was on November 17, 2025
When does Immatics N.V. report earnings?
The next expected earnings date for Immatics N.V. is March 26, 2026
Data Sources & References
- IMTX Official Website www.immatics.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1809196/000119312525283916/0001193125-25-283916-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1809196/000095017025045724/0000950170-25-045724-index.htm
- IMTX Profile on Yahoo Finance finance.yahoo.com/quote/IMTX
- IMTX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/imtx